Assets
(7 total)
7Total Assets
0Approved
1Phase 3 / Filed
6Phase 1–2 / Early
6Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | FLT3Small molecule | Acute Myeloid Leukemia | |
| Phase 2/3 | Serotonin transporter/5-HT receptorSmall molecule | Major Depressive Disorder | |
| Phase 1/2 | RETSmall molecule | Non-Small Cell Lung Cancer | |
HEC53856No recent activity | Phase 1 | HIF prolyl hydroxylase domain (PHD1/2/3)Small molecule | Chronic Kidney Disease |
| Phase 1 | — | Chronic Hepatitis B | |
| Phase 1 | — | Chronic Hepatitis B | |
| Phase 1 | SGLT2Small molecule | Type 2 Diabetes |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.